Eli Lilly and Company (LLY) Q4 2021 Earnings Call Transcript

LLY earnings call for the period ending December 31, 2021.

Related Keywords

Ireland ,China ,Mizuho ,Hokkaido ,Japan ,United States ,North Carolina ,Japanese ,Mike Mason ,Dave Ricks ,Andrew Baum ,Ilya Yuffa ,Eli Lilly ,Chris Shibutani ,Louise Chen Cantor Fitzgerald ,Andrew Baum Citi ,Kerry Holford ,Geoff Meacham ,Carter Gould Barclays ,Steve Scala Cowen ,Seamus Fernandez Guggenheim ,Louise Chen ,Kerry Holford Berenberg ,Tim Anderson ,Evan Seigerman ,Lauren Zierke ,Carter Gould ,Kevin Hern ,Alice Nettleton ,Steve Scala ,America Merrill Lynch ,Kento Ueha ,Anne White ,Seamus Fernandez ,Dan Skovronsky ,Mike Difiore Evercore ,Chris Shibutani Goldman Sachs ,Chris Schott ,Sara Smith ,Patrik Jonsson ,Jake Van Naarden ,Ronny Gal ,Alice Nettleton Wolfe Research Analyst ,Goldman Sachs ,Advisory Committee ,Geoff Meacham Bank ,Centers For Medicare ,Exchange Commission ,Elilly International ,Wolfe Research ,Company Analyst ,Medicaid Services ,Barclays ,Anat Ashkenazi ,Lilly Neuroscience ,Loxo Oncology ,Lilly Oncology ,Lilly Diabetes ,Lilly Immunology ,Lilly United ,Chief Executive ,Breakthrough Therapy Designation ,Emergency Use Authorization ,Vamil Divan ,Executive Officer ,Umer Raffat ,Chief Executive Officer ,Cantor Fitzgerald ,